When macrosomia is suspected at term, does induction of labor lower the risk of cesarean delivery?

Fetal and neonatal macrosomia can lead to morbidity for both mother and infant. Larger babies put the mother at risk of cesarean delivery, severe perineal lacerations, and hemorrhage. The macrosomic fetus faces an elevated risk of birth trauma, shoulder dystocia, and metabolic disorders.

Earlier investigations have concluded that induction of labor does not improve outcomes and may increase the risk of cesarean delivery.¹ The American Congress of Obstetricians and Gynecologists (ACOG) does not support suspected fetal macrosomia as an indication for induction of labor.²

Details of the study

The objective of this study was to determine whether women who were carrying a macrosomic fetus and who underwent induction of labor had a higher rate of cesarean delivery than those who were managed expectantly. Using data from the 2003 Vital Statistics Natality birth certificate registry, Cheng and colleagues compared women who underwent induction of labor at 39 weeks with women who were managed expectantly and who delivered at 40, 41, or 42 weeks (by induced or spontaneous labor).

Investigators attempted to adjust for normal gestational growth by assuming a fetal weight gain of 200 g for each additional week of gestation in the women managed expectantly. For instance, one group included women who delivered at 39 weeks (birth weight of 3,875–4,125 g), and they were compared with the group of women who delivered at 40 weeks (birth weight of 4,075–4,325 g), 41 weeks (4,275–4,525 g), and 42 weeks (4,475–4,725 g).

Using this scheme, cesarean delivery was lower in the group of women who underwent induction of labor. The induced groups were also found to have lower odds of composite neonatal morbidity.

Strengths and limitations

Because this was a retrospective study, investigators were able to use known birth weights, rather than estimated birth weights, to overcome misclassifications that can arise with estimates.

Cheng and colleagues refuted the findings of earlier studies that found a higher risk of cesarean delivery with induction of labor. They argued that those investigations compared women who underwent induction of labor with those who experienced spontaneous labor instead of the proper comparison—between women who underwent induction of labor and those who were managed expectantly. Although the comparisons they used in this study alleviate that problem, the retrospective nature of the study necessitated the use of multiple assumptions to allocate each group, creating selection bias.

Group allocations and medical histories cannot be confirmed, and the investigators acknowledge that their conclusions regarding neonatal morbidity lack statistical power.

We want to hear from you! Tell us what you think.

Fetal and neonatal macrosomia can lead to morbidity for both mother and infant. Larger babies put the mother at risk of cesarean delivery, severe perineal lacerations, and hemorrhage. The macrosomic fetus faces an elevated risk of birth trauma, shoulder dystocia, and metabolic disorders.

Earlier investigations have concluded that induction of labor does not improve outcomes and may increase the risk of cesarean delivery.¹ The American Congress of Obstetricians and Gynecologists (ACOG) does not support suspected fetal macrosomia as an indication for induction of labor.²

Details of the study

The objective of this study was to determine whether women who were carrying a macrosomic fetus and who underwent induction of labor had a higher rate of cesarean delivery than those who were managed expectantly. Using data from the 2003 Vital Statistics Natality birth certificate registry, Cheng and colleagues compared women who underwent induction of labor at 39 weeks with women who were managed expectantly and who delivered at 40, 41, or 42 weeks (by induced or spontaneous labor).

Investigators attempted to adjust for normal gestational growth by assuming a fetal weight gain of 200 g for each additional week of gestation in the women managed expectantly. For instance, one group included women who delivered at 39 weeks (birth weight of 3,875–4,125 g), and they were compared with the group of women who delivered at 40 weeks (birth weight of 4,075–4,325 g), 41 weeks (4,275–4,525 g), and 42 weeks (4,475–4,725 g).

Using this scheme, cesarean delivery was lower in the group of women who underwent induction of labor. The induced groups were also found to have lower odds of composite neonatal morbidity.

Strengths and limitations

Because this was a retrospective study, investigators were able to use known birth weights, rather than estimated birth weights, to overcome misclassifications that can arise with estimates.

Cheng and colleagues refuted the findings of earlier studies that found a higher risk of cesarean delivery with induction of labor. They argued that those investigations compared women who underwent induction of labor with those who experienced spontaneous labor instead of the proper comparison—between women who underwent induction of labor and those who were managed expectantly. Although the comparisons they used in this study alleviate that problem, the retrospective nature of the study necessitated the use of multiple assumptions to allocate each group, creating selection bias.

Group allocations and medical histories cannot be confirmed, and the investigators acknowledge that their conclusions regarding neonatal morbidity lack statistical power.

We want to hear from you! Tell us what you think.

Fetal and neonatal macrosomia can lead to morbidity for both mother and infant. Larger babies put the mother at risk of cesarean delivery, severe perineal lacerations, and hemorrhage. The macrosomic fetus faces an elevated risk of birth trauma, shoulder dystocia, and metabolic disorders.

Earlier investigations have concluded that induction of labor does not improve outcomes and may increase the risk of cesarean delivery.¹ The American Congress of Obstetricians and Gynecologists (ACOG) does not support suspected fetal macrosomia as an indication for induction of labor.²

Details of the study

The objective of this study was to determine whether women who were carrying a macrosomic fetus and who underwent induction of labor had a higher rate of cesarean delivery than those who were managed expectantly. Using data from the 2003 Vital Statistics Natality birth certificate registry, Cheng and colleagues compared women who underwent induction of labor at 39 weeks with women who were managed expectantly and who delivered at 40, 41, or 42 weeks (by induced or spontaneous labor).

Investigators attempted to adjust for normal gestational growth by assuming a fetal weight gain of 200 g for each additional week of gestation in the women managed expectantly. For instance, one group included women who delivered at 39 weeks (birth weight of 3,875–4,125 g), and they were compared with the group of women who delivered at 40 weeks (birth weight of 4,075–4,325 g), 41 weeks (4,275–4,525 g), and 42 weeks (4,475–4,725 g).

Using this scheme, cesarean delivery was lower in the group of women who underwent induction of labor. The induced groups were also found to have lower odds of composite neonatal morbidity.

Strengths and limitations

Because this was a retrospective study, investigators were able to use known birth weights, rather than estimated birth weights, to overcome misclassifications that can arise with estimates.

Cheng and colleagues refuted the findings of earlier studies that found a higher risk of cesarean delivery with induction of labor. They argued that those investigations compared women who underwent induction of labor with those who experienced spontaneous labor instead of the proper comparison—between women who underwent induction of labor and those who were managed expectantly. Although the comparisons they used in this study alleviate that problem, the retrospective nature of the study necessitated the use of multiple assumptions to allocate each group, creating selection bias.

Group allocations and medical histories cannot be confirmed, and the investigators acknowledge that their conclusions regarding neonatal morbidity lack statistical power.

We want to hear from you! Tell us what you think.